REIT - Retail
Compare Stocks
2 / 10Stock Comparison
ALX vs WELL
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
ALX vs WELL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | REIT - Retail | REIT - Healthcare Facilities |
| Market Cap | $1.30B | $151.66B |
| Revenue (TTM) | $212M | $11.63B |
| Net Income (TTM) | $21M | $1.43B |
| Gross Margin | 63.6% | 39.1% |
| Operating Margin | 28.3% | 4.4% |
| Forward P/E | 21.0x | 79.7x |
| Total Debt | $943M | $21.38B |
| Cash & Equiv. | $128M | $5.03B |
ALX vs WELL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Alexander's, Inc. (ALX) | 100 | 97.7 | -2.3% |
| Welltower Inc. (WELL) | 100 | 427.2 | +327.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ALX vs WELL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ALX is the clearest fit if your priority is defensive.
- Beta 0.35, yield 7.1%, current ratio 8.33x
- Lower P/E (21.0x vs 79.7x)
- 7.1% yield, vs WELL's 1.3%
WELL carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 0.13, yield 1.3%
- Rev growth 35.8%, EPS growth -11.5%, 3Y rev CAGR 22.7%
- 233.9% 10Y total return vs ALX's 11.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs ALX's -5.8% | |
| Value | Lower P/E (21.0x vs 79.7x) | |
| Quality / Margins | 12.3% margin vs ALX's 9.7% | |
| Stability / Safety | Beta 0.13 vs ALX's 0.35, lower leverage | |
| Dividends | 7.1% yield, vs WELL's 1.3% | |
| Momentum (1Y) | +45.8% vs ALX's +30.3% | |
| Efficiency (ROA) | 2.3% ROA vs ALX's 2.2%, ROIC 0.5% vs 5.2% |
ALX vs WELL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ALX vs WELL — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — ALX and WELL each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 54.9x ALX's $212M. Profitability is closely matched — net margins range from 12.3% (WELL) to 9.7% (ALX). On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $212M | $11.6B |
| EBITDAEarnings before interest/tax | $97M | $2.8B |
| Net IncomeAfter-tax profit | $21M | $1.4B |
| Free Cash FlowCash after capex | $65M | $2.5B |
| Gross MarginGross profit ÷ Revenue | +63.6% | +39.1% |
| Operating MarginEBIT ÷ Revenue | +28.3% | +4.4% |
| Net MarginNet income ÷ Revenue | +9.7% | +12.3% |
| FCF MarginFCF ÷ Revenue | +30.5% | +21.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.7% | +40.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -62.1% | +22.5% |
Valuation Metrics
ALX leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 46.2x trailing earnings, ALX trades at a 70% valuation discount to WELL's 155.7x P/E. On an enterprise value basis, ALX's 21.1x EV/EBITDA is more attractive than WELL's 67.4x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $1.3B | $151.7B |
| Enterprise ValueMkt cap + debt − cash | $2.1B | $168.0B |
| Trailing P/EPrice ÷ TTM EPS | 46.18x | 155.73x |
| Forward P/EPrice ÷ next-FY EPS est. | 21.02x | 79.69x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 21.07x | 67.37x |
| Price / SalesMarket cap ÷ Revenue | 6.08x | 14.22x |
| Price / BookPrice ÷ Book value/share | 11.95x | 3.40x |
| Price / FCFMarket cap ÷ FCF | 17.66x | 53.25x |
Profitability & Efficiency
ALX leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
ALX delivers a 17.4% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $3 for WELL. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to ALX's 8.64x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs ALX's 4/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +17.4% | +3.5% |
| ROA (TTM)Return on assets | +2.2% | +2.3% |
| ROICReturn on invested capital | +5.2% | +0.5% |
| ROCEReturn on capital employed | +5.5% | +0.6% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 |
| Debt / EquityFinancial leverage | 8.64x | 0.49x |
| Net DebtTotal debt minus cash | $815M | $16.3B |
| Cash & Equiv.Liquid assets | $128M | $5.0B |
| Total DebtShort + long-term debt | $943M | $21.4B |
| Interest CoverageEBIT ÷ Interest expense | 1.55x | 0.26x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $31,193 today (with dividends reinvested), compared to $12,285 for ALX. Over the past 12 months, WELL leads with a +45.8% total return vs ALX's +30.3%. The 3-year compound annual growth rate (CAGR) favors WELL at 43.3% vs ALX's 20.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +18.1% | +16.2% |
| 1-Year ReturnPast 12 months | +30.3% | +45.8% |
| 3-Year ReturnCumulative with dividends | +75.2% | +194.0% |
| 5-Year ReturnCumulative with dividends | +22.8% | +211.9% |
| 10-Year ReturnCumulative with dividends | +11.7% | +233.9% |
| CAGR (3Y)Annualised 3-year return | +20.6% | +43.3% |
Risk & Volatility
WELL leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
WELL is the less volatile stock with a 0.13 beta — it tends to amplify market swings less than ALX's 0.35 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.35x | 0.13x |
| 52-Week HighHighest price in past year | $260.84 | $219.59 |
| 52-Week LowLowest price in past year | $201.28 | $142.65 |
| % of 52W HighCurrent price vs 52-week peak | +97.4% | +98.6% |
| RSI (14)Momentum oscillator 0–100 | 57.5 | 57.6 |
| Avg Volume (50D)Average daily shares traded | 55K | 2.6M |
Analyst Outlook
Evenly matched — ALX and WELL each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates ALX as "Buy" and WELL as "Buy". Consensus price targets imply 4.6% upside for WELL (target: $227) vs -50.8% for ALX (target: $125). For income investors, ALX offers the higher dividend yield at 7.09% vs WELL's 1.28%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $125.00 | $226.50 |
| # AnalystsCovering analysts | 2 | 34 |
| Dividend YieldAnnual dividend ÷ price | +7.1% | +1.3% |
| Dividend StreakConsecutive years of raises | 0 | 2 |
| Dividend / ShareAnnual DPS | $18.00 | $2.76 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
ALX leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). WELL leads in 2 (Total Returns, Risk & Volatility). 2 tied.
ALX vs WELL: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is ALX or WELL a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus -5. 8% for Alexander's, Inc. (ALX). Alexander's, Inc. (ALX) offers the better valuation at 46. 2x trailing P/E (21. 0x forward), making it the more compelling value choice. Analysts rate Alexander's, Inc. (ALX) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ALX or WELL?
On trailing P/E, Alexander's, Inc.
(ALX) is the cheapest at 46. 2x versus Welltower Inc. at 155. 7x. On forward P/E, Alexander's, Inc. is actually cheaper at 21. 0x.
03Which is the better long-term investment — ALX or WELL?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +211. 9%, compared to +22. 8% for Alexander's, Inc. (ALX). Over 10 years, the gap is even starker: WELL returned +233. 9% versus ALX's +11. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ALX or WELL?
By beta (market sensitivity over 5 years), Welltower Inc.
(WELL) is the lower-risk stock at 0. 13β versus Alexander's, Inc. 's 0. 35β — meaning ALX is approximately 161% more volatile than WELL relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 9% for Alexander's, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ALX or WELL?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus -5. 8% for Alexander's, Inc. (ALX). On earnings-per-share growth, the picture is similar: Welltower Inc. grew EPS -11. 5% year-over-year, compared to -35. 0% for Alexander's, Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ALX or WELL?
Alexander's, Inc.
(ALX) is the more profitable company, earning 13. 2% net margin versus 8. 8% for Welltower Inc. — meaning it keeps 13. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALX leads at 30. 6% versus 3. 3% for WELL. At the gross margin level — before operating expenses — WELL leads at 39. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ALX or WELL more undervalued right now?
On forward earnings alone, Alexander's, Inc.
(ALX) trades at 21. 0x forward P/E versus 79. 7x for Welltower Inc. — 58. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for WELL: 4. 6% to $226. 50.
08Which pays a better dividend — ALX or WELL?
All stocks in this comparison pay dividends.
Alexander's, Inc. (ALX) offers the highest yield at 7. 1%, versus 1. 3% for Welltower Inc. (WELL).
09Is ALX or WELL better for a retirement portfolio?
For long-horizon retirement investors, Welltower Inc.
(WELL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 13), 1. 3% yield, +233. 9% 10Y return). Both have compounded well over 10 years (WELL: +233. 9%, ALX: +11. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ALX and WELL?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ALX is a small-cap income-oriented stock; WELL is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.